MAM
PRVL

Martingale Asset Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Martingale Asset Management’s Portfolio PRVL Stock Details PRVL Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-39,608
Closed -$404K – 1100
2020
Q3 		$404K Buy
+39,608
New +$404K ﹤0.01% 856